Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBbva Ord Regulatory News (BVA)

Share Price Information for Bbva Ord (BVA)

Share Price is delayed by 15 minutes
Get Live Data
19.80    -0.10 (-0.50%)
Bid:
18.90
Ask:
19.80
Spread: 0.90 (4.762%)
Market Cap: €110.04b
BVA Live PriceLast checked at - London Stock Exchange

Intraday Bbva Ord Share Chart

AGM Statement

4 Feb 2015 07:00

RNS Number : 9663D
Banco Bilbao Vizcaya Argentaria SA
03 February 2015
 

 

 

 

 

 

 

 

TO THE CNMV (SECURITIES EXCHANGE COMMISSION)

 

 

 

Banco Bilbao Vizcaya Argentaria, S.A.(BBVA), in compliance with the Securities Exchange legislation, hereby files the following

 

 

RELEVANT EVENT

 

 

BBVA´s Board of Directors has resolved today to call the Annual General Meeting of Shareholders to be held in Bilbao, at Palacio Euskalduna, calle Abandoibarra number 4 on 12th March 2015, at 12:00 at first summons, and in the same place and at the same time on 13th March 2015 at second summons. It will have the agenda attached.

 

 

 

Madrid, 3rd February 2015

 

 

 

 

 

 

 

 

 

2015 ANNUAL GENERAL MEETING OF SHAREHOLDERS

 

AGENDA

 

ONE.- Financial statements, profit allocation and corporate management:

 

1.1 Examination and approval of the annual financial statements and management reports of Banco Bilbao Vizcaya Argentaria, S.A. and its consolidated group corresponding to the year ending on 31 December 2014.

1.2. Approval of the allocation of the 2014 profit or losses.

1.3 Approval of corporate management during 2014.

 

TWO.- Adoption of the following resolutions regarding the re-election and appointment of members to the Board of Directors:

 

2.1 Re-election of Mr. José Antonio Fernández Rivero

 

2.2. Re-election of Mrs. Belén Garijo López

 

2.3 Re-election of Mr. José Maldonado Ramos

 

2.4 Re-election of Mr. Juan Pi Llorens

 

2.5 Appointment of Mr. José Miguel Andrés Torrecillas

 

Pursuant to paragraph 2 of article 34 of the Company Bylaws, determination of the number of directors at the number resulting from the resolutions adopted under this agenda item, which will be reported to the General Meeting for all due effects.

 

THREE.-  Conferral on the Board of Directors of the authority to issue, directly or through subsidiary companies with the Bank's guarantee, financial instruments of any sort that recognise or create debt of any class or nature, not convertible into newly issued shares, up to a maximum nominal amount of two hundred and fifty billion euros (€250,000,000,000).

 

FOUR.- Approve four capital increases to be charged to reserves in order to implement the BBVA shareholder remuneration system called "Dividend Option":

4.1 Increase the share capital, charged to voluntary reserves, according to the terms of the resolution by issuing new ordinary shares each with a nominal value of forty-nine euro cents (€0.49), without issue premium, of the same class and series as the shares currently in circulation. Commitment to purchase shareholders' free allocation rights at a guaranteed fixed price. Express possibility of undersubscription. Conferral of authority on the Board of Directors to determine the execution date of the increase and its conditions when not established by this General Meeting, to take the measures necessary for its execution and to adapt the wording of article 5 of the Company Bylaws to the new figure for the resulting share capital. Application before the competent national and foreign organisms for admitting negotiations for new shares on the Spanish and foreign Securities Exchanges on which Banco Bilbao Vizcaya Argentaria, S.A. shares are traded in the required manner for each one.

4.2 Increase the share capital, charged to voluntary reserves, according to the terms of the resolution by issuing new ordinary shares each with a nominal value of forty-nine euro cents (€0.49), without issue premium, of the same class and series as the shares currently in circulation. Commitment to purchase shareholders' free allocation rights at a guaranteed fixed price. Express possibility of undersubscription. Conferral of authority on the Board of Directors to determine the execution date of the increase and its conditions when not established by this General Meeting, to take the measures necessary for its execution and to adapt the wording of article 5 of the Company Bylaws to the new figure for the resulting share capital. Application before the competent national and foreign organisms for admitting negotiations for new shares on the Spanish and foreign Securities Exchanges on which Banco Bilbao Vizcaya Argentaria, S.A. shares are traded in the required manner for each one.

4.3 Increase the share capital, charged to voluntary reserves, according to the terms of the resolution by issuing new ordinary shares each with a nominal value of forty-nine euro cents (€0.49), without issue premium, of the same class and series as the shares currently in circulation. Commitment to purchase shareholders' free allocation rights at a guaranteed fixed price. Express possibility of undersubscription. Conferral of authority on the Board of Directors to determine the execution date of the increase and its conditions when not established by this General Meeting, to take the measures necessary for its execution and to adapt the wording of article 5 of the Company Bylaws to the new figure for the resulting share capital. Application before the competent national and foreign organisms for admitting negotiations for new shares on the Spanish and foreign Securities Exchanges on which Banco Bilbao Vizcaya Argentaria, S.A. shares are traded in the required manner for each one.

4.4 Increase the share capital, charged to voluntary reserves, according to the terms of the resolution by issuing new ordinary shares each with a nominal value of forty-nine euro cents (€0.49), without issue premium, of the same class and series as the shares currently in circulation. Commitment to purchase shareholders' free allocation rights at a guaranteed fixed price. Express possibility of undersubscription. Conferral of authority on the Board of Directors to determine the execution date of the increase and its conditions when not established by this General Meeting, to take the measures necessary for its execution and to adapt the wording of article 5 of the Company Bylaws to the new figure for the resulting share capital. Application before the competent national and foreign organisms for admitting negotiations for new shares on the Spanish and foreign Securities Exchanges on which Banco Bilbao Vizcaya Argentaria, S.A. shares are traded in the required manner for each one.

 

FIVE.- Approve the amendment of the Company Bylaws:

5.1 Approve the amendment of the following articles of the Company Bylaws concerning the General Meeting to incorporate improvements in the regulation thereof in light of new developments in legislation, including, in particular, Law 31/2014 of 3 December, which amends the Corporate Enterprises Act insofar as improving corporate governance: Article 20. Announcement; Article 24. Representation to attend the Meeting; Article 29. Shareholders' right to information; and Article 30. Powers of the General Meeting.

5.2 Approve the creation of a new Article 39 bis regarding the Lead Director, and the amendment of the following articles in the Company Bylaws, all concerning the operations of the Board of Directions and the Executive Committee, to incorporate improvements in the regulation thereof in light of new developments in legislation, including, in particular, Law 31/2014 of 3 December, which amends the Corporate Enterprises Act insofar as improving corporate governance: Article 37. Vacancies; Article 40. Board Meeting and Announcement; Article 42. Representation to attend the Board; and Article 46. Meeting and Powers (of the Executive Committee).

5.3 Approve the amendment of Article 48 of the Company Bylaws concerning Audit Committee for incorporating the contemplation of committees that must be established by law therein in light of new developments in legislation, including, in particular, Law 31/2014 of 3 December, which amends the Corporate Enterprises Act insofar as improving corporate governance.

 

SIX.- Approve the amendment of the following articles of the General Shareholders Meeting Regulations to incorporate improvements in the regulation thereof in light of new developments in legislation, including, in particular, Law 31/2014 of 3 December, which amends the Corporate Enterprises Act insofar as improving corporate governance: Article 3. Powers of the General Meeting; Article 4. Announcement; Article 5. Publication of the announcement; Article 5 bis. Supplement to the announcement and new agreement proposals; Article 6. Shareholders' right to information prior to the meeting; and Article 9. Representation to attend the Meeting.

SEVEN.- Approval of the Remuneration Policy for Board Members of BBVA, which includes maximum number of shares to be delivered through its execution.

 

EIGHT.- Approval of the extension of the group of employees to whom the maximum limit of variable remuneration of up to 200% of the fixed component is applicable.

 

NINE.- Re-election of the firm to audit the accounts of Banco Bilbao Vizcaya Argentaria, S.A. and its consolidated Group in 2015.

 

TEN.- Conferral of authority on the Board of Directors, which may in turn delegate such authority, to formalise, correct, interpret and implement the decisions adopted by the General Meeting.

 

ELEVEN.- Consultative vote on the Annual Report on Directors' Remuneration of BBVA.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMSSMFADFISEDE
Date   Source Headline
5th Apr 20174:51 pmRNSFinal Terms GMTN Programme
3rd Apr 20179:31 amRNSPre Stabilisation Notice
30th Mar 20177:00 amRNSDividend Option Information April 2017
22nd Mar 20178:12 amRNSBBVA completes the acquisition of 9.95% of Garanti
20th Mar 20177:00 amRNSBasel Accord Pillar III
17th Mar 20173:05 pmRNSDividend Option April 2017
17th Mar 20172:58 pmRNSResolutions adopted by the General Meeting
16th Mar 20171:36 pmRNSFinal Terms GMTN Programme
14th Mar 20173:55 pmRNSFinal Terms GMTN Programme
8th Mar 201711:36 amRNSDBRS has assigned BBVA an Issuer Rating
24th Feb 20173:49 pmRNSSupplemental to the Offering Circular GMTN
24th Feb 201710:29 amRNSFinal Terms GMTN Programme
22nd Feb 20177:00 amRNSAcquisition agreement 9,95% of Garanti
14th Feb 20174:07 pmRNSSupplemental to the Offering Circular
14th Feb 20171:26 pmRNSBBVA Annual Report 2016 (spanish version)
14th Feb 20171:22 pmRNSBBVA Annual Report 2016
14th Feb 20179:06 amRNSNotice of AGM
10th Feb 20177:00 amRNSAnnual General Meeting 2017 Call
8th Feb 20173:04 pmRNSFinal Terms - Global Medium Term Note Programme
6th Feb 201710:15 amRNSPost-Stab Notice BBVA EUR 5yr Senior
3rd Feb 20173:34 pmRNSStabilisation Notice
2nd Feb 20178:37 amRNSStabilisation Notice - BBVA T2
1st Feb 20174:36 pmRNSSupplemental to the Offering Circular
1st Feb 20177:16 amRNS4Q16 Results Presentation
1st Feb 20177:10 amRNS4Q16 Results Report
1st Feb 20177:05 amRNSPress Release 4Q16 Results
1st Feb 20177:00 amRNSShareholder Remuneration Policy
27th Jan 20177:48 amRNS4Q16 Results presentation announcement
23rd Jan 20177:46 amRNSRDL Mortgage Floor Clauses
11th Jan 201712:09 pmRNSFinal Terms Global Medium Term Note Programme
5th Jan 201710:10 amRNSPre Stabilisation Notice BBVA EUR 5yr Senior
4th Jan 20173:21 pmRNSPublication of Approved ECP Supplement
28th Dec 20167:00 amRNSSupplemental to the Offering Circular
22nd Dec 20163:51 pmRNSPublication of approved ECP Listing Particulars
22nd Dec 20167:00 amRNSDividend January 2017
21st Dec 20162:23 pmRNSMortgage Floor Clauses
19th Dec 201610:43 amRNSSupplemental to the Offering Circular
1st Dec 20167:48 amRNSSREP capital requirement
25th Nov 20161:24 pmRNSOffering Circular
23rd Nov 20165:44 pmRNSBBVA SA Annual Report 2015
23rd Nov 20165:28 pmRNSBBVA SA Annual Report 2014
23rd Nov 20165:19 pmRNSForm 6-K
23rd Nov 20165:04 pmRNSForm 20-F 2015
7th Nov 20163:32 pmRNSSupplemental to the Offering Circular
4th Nov 201612:18 pmRNSDividend Option
27th Oct 20167:00 amRNS3rd Quarter Results Presentation
27th Oct 20167:00 amRNS3rd Quarter Results Information
27th Oct 20167:00 amRNS3rd Quarter Results
24th Oct 20165:02 pmRNSHR 3Q16 Results presentation announcement
20th Oct 20167:00 amRNSEnding trading period Divend Option October 2016

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.